Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer

Clinical Genitourinary Cancer

Volumn 10, Issue 1, 2012, Pages 15-20

  Tsao, Che Kai ^a   Moshier, Erin ^a   Seng, Sonia M ^a   Godbold, James ^a   Grossman, Steven ^a   Winston, Jonathan ^a   Oh, William K ^a   Galsky, Matthew D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder Cancer; CG Formula; Cisplatin Eligibility; CKD EPI Formula; MDRD Formula

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION FORMULA; CLINICAL DECISION MAKING; COCKROFT GAULT FORMULA; CREATININE CLEARANCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; TRANSITIONAL CELL CARCINOMA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; CREATININE; ELIGIBILITY DETERMINATION; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEX FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84857230395     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2011.10.004     Document Type: Article

References (17)

1. M. Shelley, A. Cleves, T.J. Wilt Gemcitabine for unresectable, locally advanced or metastatic bladder cancer Cochrane Database Syst Rev 4 2011 CD008976
2. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer. a randomised controlled trial. International collaboration of trialists Lancet 354 1999 533 540
3. H.B. Grossman, R.B. Natale, C.M. Tangen Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866 (Pubitemid 37025405)
4. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Eur Urol 48 2005 189 199 discussion 99-201
5. M.D. Galsky, N.M. Hahn, J. Rosenberg Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based chemotherapy J Clin Oncol 29 2011 2432 2438
6. M.D. Galsky, G.J. Chen, W.K. Oh Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma Ann Oncol 2011 May 4 [Epub ahead of print]
7. J. M. McKiernan GJD, S. Gilbert, V. Grann, C. A. Olsson, D. Petrylak, M. Benson. Factors associated with perioperative systemic chemotherapy for bladder cancer: a population based study. Abstract presented: at American Society of Clinical Oncology annual meeting, Orlando, FL, USA 2005.
8. A. Dash, M.D. Galsky, A.J. Vickers Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder Cancer 107 2006 506 513 (Pubitemid 44107210)
9. D. Canter, R. Viterbo, A. Kutikov Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy Urology 77 2011 160 165
10. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
11. M.I. Milowsky, D.M. Nanus, F.C. Maluf Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium J Clin Oncol 27 2009 4062 4067
12. J.E. Uhm, H.Y. Lim, W.S. Kim Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract Neoplasia 9 2007 18 22
13. M.D. Galsky, N.M. Hahn, J. Rosenberg A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy Lancet Oncol 12 2011 211 214
14. G.V. Raj, S. Karavadia, B. Schlomer Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer Cancer 117 2011 276 282
15. E. Davila, L.B. Gardner Clinical-value of the creatinine clearance before the administration of chemotherapy with cisplatin Cancer 60 1987 161 164 (Pubitemid 17092249)
16. V. Launay-Vacher, E. Chatelut, S.M. Lichtman Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations Ann Oncol 18 2007 1314 1321 (Pubitemid 47305003)
17. Guidance for Industry Pharmacokinetics in Patients with Impaired Renal Function Study Design, Data Analysis, and Impact on Dosing and Labeling U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research 2010 http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM204959.pdf Accessed: June 22, 2011